Trials / Completed
CompletedNCT02432404
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To assess potential benefits associated with both intermittent (use for 3 weeks, remove for 1 week, as defined in the package insert) and continuous (use for 4 weeks, then replace) CVR use among women either with BV or at high risk for BV. The investigators will also recruit women who are HSV2-infected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NuvaRing |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2021-11-01
- Completion
- 2021-11-01
- First posted
- 2015-05-04
- Last updated
- 2025-02-05
- Results posted
- 2025-02-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02432404. Inclusion in this directory is not an endorsement.